Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Industry
Laboratory Analytical Instruments
Location
47215 Lakeview Boulevard, Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 685 % -13.6%
Quick Ratio 93.6 % -18.5%
Debt-to-equity 25.7 % +8.62%
Return On Equity -1.39 % -116%
Return On Assets -1.13 % -106%
Operating Margin -11.8 % +90.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 129M shares -4.97%
Common Stock, Shares, Outstanding 130M shares -4.26%
Entity Public Float 1.03B USD
Common Stock, Value, Issued 130K USD -4.41%
Weighted Average Number of Shares Outstanding, Basic 131M shares -3.8%
Weighted Average Number of Shares Outstanding, Diluted 133M shares -2.49%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 201M USD +813%
Revenue from Contract with Customer, Excluding Assessed Tax 201M USD +9.88%
Research and Development Expense 40.5M USD -5.76%
Selling and Marketing Expense 48.8M USD +4.68%
General and Administrative Expense 44.8M USD +2.44%
Operating Income (Loss) -23.6M USD +14.4%
Nonoperating Income (Expense) 11.7M USD -1.55%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.9M USD +24.2%
Income Tax Expense (Benefit) -1.75M USD +1.18%
Net Income (Loss) Attributable to Parent -5.85M USD -125%
Earnings Per Share, Basic 0.02 USD/shares
Earnings Per Share, Diluted 0.02 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 162M USD -0.83%
Accounts Receivable, after Allowance for Credit Loss, Current 52.6M USD -5%
Inventory, Net 46.8M USD -30%
Other Assets, Current 2.34M USD +4.04%
Assets, Current 390M USD -7.61%
Property, Plant and Equipment, Net 18.5M USD +6.28%
Operating Lease, Right-of-Use Asset 10.1M USD -13.5%
Intangible Assets, Net (Excluding Goodwill) 20.5M USD -15.6%
Goodwill 16.2M USD -1.67%
Other Assets, Noncurrent 4.95M USD +56.3%
Assets 491M USD -5.43%
Accrued Liabilities, Current 20.7M USD +1.07%
Contract with Customer, Liability, Current 40.2M USD +5.65%
Liabilities, Current 62.8M USD +6.99%
Operating Lease, Liability, Noncurrent 7.76M USD -23.5%
Other Liabilities, Noncurrent 2.12M USD -7.18%
Liabilities 106M USD +1.79%
Accumulated Other Comprehensive Income (Loss), Net of Tax 101K USD
Retained Earnings (Accumulated Deficit) -44.8M USD -29.3%
Stockholders' Equity Attributable to Parent 385M USD -7.23%
Liabilities and Equity 491M USD -5.43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 3.96M USD +38.5%
Net Cash Provided by (Used in) Financing Activities 1.61M USD
Net Cash Provided by (Used in) Investing Activities -5.75M USD +96.6%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 130M shares -4.26%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.51M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 162M USD -0.81%
Deferred Tax Assets, Valuation Allowance 2.27M USD +81.7%
Deferred Tax Assets, Gross 36M USD +39.7%
Operating Lease, Liability 11.3M USD -13.3%
Depreciation 3.4M USD +30.8%
Payments to Acquire Property, Plant, and Equipment 567K USD +12.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -8.48M USD +43.4%
Lessee, Operating Lease, Liability, to be Paid 11.8M USD -14.9%
Property, Plant and Equipment, Gross 26.5M USD +18.1%
Operating Lease, Liability, Current 3.53M USD +22.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.5M USD -6.04%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.66M USD +19.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure +38.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 501K USD -39.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.32M USD -9.96%
Deferred Tax Assets, Operating Loss Carryforwards 1.41M USD +87.3%
Unrecognized Tax Benefits 3.64M USD +62.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.05M USD -11.6%
Additional Paid in Capital 430M USD -4.78%
Amortization of Intangible Assets 3.6M USD +75.9%
Depreciation, Depletion and Amortization 1.7M USD +69.7%
Deferred Tax Assets, Net of Valuation Allowance 33.7M USD +37.5%
Share-based Payment Arrangement, Expense 25.5M USD +22.4%
Interest Expense 1.84M USD -30.8%